AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Drug Type (Riluzole and Edaravone (Radicava)), By Distribution Channel (Hospital Pharmacies, and Retail & Online Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI1206
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease (MND), is a neurodegenerative disease, affecting nerve cells in the brain and spinal cord that controls voluntary muscles. The disease is progressive in nature, meaning it gets worse over time.